Toxicity Clinical Trial
Official title:
Assessment of Peroxide Level in Saliva During Teeth Bleaching With 9.5% Hydrogen Peroxide Gel Using a Tray With Reservoir Versus a Tray Without Reservoir. A Randomized Clinical Trial
Verified date | May 2024 |
Source | Cairo University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Assessment of peroxide level in saliva during teeth bleaching with 9.5% hydrogen peroxide gel using a tray with reservoir versus a tray without reservoir. A randomized clinical trial
Status | Completed |
Enrollment | 34 |
Est. completion date | May 8, 2024 |
Est. primary completion date | February 20, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 40 Years |
Eligibility | Inclusion Criteria: - participants: 1. Good general health. 2. Adult patients aged 18-40 years. 3. Absence of non-carious cervical lesions, active caries, gingival recession, or periodontal disease. 4. Do not use orthodontics appliance or removable prosthesis. teeth: 1. Maxillary anterior teeth without caries, restorations and/or endodontic treatment. 2. Mild generalized staining. Exclusion Criteria: - participants: 1. Smoking or alcohol dependent patients. 2. Pregnancy and lactating women. 3. Parafunctional habits or pathologies. 4. Periapical alterations. 5. Use of medicaments that alter salivary flow. 6. Patients who had already undergone tooth bleaching 7. Patients with severe internal tooth discoloration as tetracycline stain, fluorosis or endodontic treatment. teeth: 1. Tooth hypersensitivity. 2. Presence of cracks or fractures. 3. Periodontal affection sign and symptoms. |
Country | Name | City | State |
---|---|---|---|
Egypt | Faculty of dentistry | Cairo |
Lead Sponsor | Collaborator |
---|---|
Cairo University |
Egypt,
Alqahtani MQ. Tooth-bleaching procedures and their controversial effects: A literature review. Saudi Dent J. 2014 Apr;26(2):33-46. doi: 10.1016/j.sdentj.2014.02.002. Epub 2014 Mar 12. — View Citation
Auschill TM, Hellwig E, Schmidale S, Sculean A, Arweiler NB. Efficacy, side-effects and patients' acceptance of different bleaching techniques (OTC, in-office, at-home). Oper Dent. 2005 Mar-Apr;30(2):156-63. — View Citation
Bernardon JK, Sartori N, Ballarin A, Perdigao J, Lopes GC, Baratieri LN. Clinical performance of vital bleaching techniques. Oper Dent. 2010 Jan-Feb;35(1):3-10. doi: 10.2341/09-008CR. — View Citation
Dahl JE, Pallesen U. Tooth bleaching--a critical review of the biological aspects. Crit Rev Oral Biol Med. 2003;14(4):292-304. doi: 10.1177/154411130301400406. — View Citation
Geisinger S, Kwon SR, Qian F. Employment of Reservoirs in At-Home Whitening Trays: Efficacy and Efficiency in Tooth Whitening. J Contemp Dent Pract. 2015 May 1;16(5):383-8. doi: 10.5005/jp-journals-10024-1694. — View Citation
Goldberg M, Grootveld M, Lynch E. Undesirable and adverse effects of tooth-whitening products: a review. Clin Oral Investig. 2010 Feb;14(1):1-10. doi: 10.1007/s00784-009-0302-4. Epub 2009 Jun 20. — View Citation
Hannig C, Willenbucher S, Becker K, Mahony C, Attin T. Recovery of peroxides in saliva during home bleaching--influence of smoking. J Oral Rehabil. 2006 Jul;33(7):533-41. doi: 10.1111/j.1365-2842.2005.01579.x. — View Citation
Hannig C, Zech R, Henze E, Dorr-Tolui R, Attin T. Determination of peroxides in saliva--kinetics of peroxide release into saliva during home-bleaching with Whitestrips and Vivastyle. Arch Oral Biol. 2003 Aug;48(8):559-66. doi: 10.1016/s0003-9969(03)00102-x. — View Citation
Hannig C, Zech R, Henze E, Dreier S, Attin T. Peroxide release into saliva from five different home bleaching systems in vivo. Am J Dent. 2005 Feb;18(1):13-8. — View Citation
Haywood VB, Leonard RH, Nelson CF, Brunson WD. Effectiveness, side effects and long-term status of nightguard vital bleaching. J Am Dent Assoc. 1994 Sep;125(9):1219-26. doi: 10.14219/jada.archive.1994.0154. — View Citation
Haywood VB, Sword RJ. Tray bleaching status and insights. J Esthet Restor Dent. 2021 Jan;33(1):27-38. doi: 10.1111/jerd.12688. Epub 2020 Dec 5. — View Citation
Haywood VB. History, safety, and effectiveness of current bleaching techniques and applications of the nightguard vital bleaching technique. Quintessence Int. 1992 Jul;23(7):471-88. — View Citation
Javaheri DS, Janis JN. The efficacy of reservoirs in bleaching trays. Oper Dent. 2000 May-Jun;25(3):149-51. — View Citation
Joiner A. The bleaching of teeth: a review of the literature. J Dent. 2006 Aug;34(7):412-9. doi: 10.1016/j.jdent.2006.02.002. Epub 2006 Mar 29. — View Citation
Kirsten GA, Freire A, de Lima AA, Ignacio SA, Souza EM. Effect of reservoirs on gingival inflammation after home dental bleaching. Quintessence Int. 2009 Mar;40(3):195-202. — View Citation
Kose C, Calixto AL, Bauer JR, Reis A, Loguercio AD. Comparison of the Effects of In-office Bleaching Times on Whitening and Tooth Sensitivity: A Single Blind, Randomized Clinical Trial. Oper Dent. 2016 Mar-Apr;41(2):138-45. doi: 10.2341/15-085-C. Epub 2015 Oct 28. — View Citation
Li Y. Safety controversies in tooth bleaching. Dent Clin North Am. 2011 Apr;55(2):255-63, viii. doi: 10.1016/j.cden.2011.01.003. — View Citation
Mailart MC, Sakassegawa PA, Torres C, Palo RM, Borges AB. Assessment of Peroxide in Saliva During and After At-home Bleaching With 10% Carbamide and Hydrogen Peroxide Gels: A Clinical Crossover Trial. Oper Dent. 2020 Jul 1;45(4):368-376. doi: 10.2341/19-127-C. — View Citation
Marques DN, da Mata AD, Silveira JM, Marques JR, Amaral JP, Guilherme NF. Hydrogen peroxide release kinetics into saliva from different whitening products: a double-blind, randomized clinical trial. Clin Oral Investig. 2012 Feb;16(1):155-63. doi: 10.1007/s00784-010-0491-x. Epub 2011 Jan 8. — View Citation
Martini EC, Favoreto MW, Coppla FM, Loguercio AD, Reis A. Evaluation of reservoirs in bleaching trays for at-home bleaching: a split-mouth single-blind randomized controlled equivalence trial. J Appl Oral Sci. 2020;28:e20200332. doi: 10.1590/1678-7757-2020-0332. Epub 2020 Aug 17. — View Citation
Martini EC, Favoreto MW, de Andrade HF, Coppla FM, Loguercio AD, Reis A. One-year follow-up evaluation of reservoirs in bleaching trays for at-home bleaching. J Esthet Restor Dent. 2021 Oct;33(7):992-998. doi: 10.1111/jerd.12797. Epub 2021 Jul 1. — View Citation
Matis BA, Hamdan YS, Cochran MA, Eckert GJ. A clinical evaluation of a bleaching agent used with and without reservoirs. Oper Dent. 2002 Jan-Feb;27(1):5-11. — View Citation
Matis BA, Yousef M, Cochran MA, Eckert GJ. Degradation of bleaching gels in vivo as a function of tray design and carbamide peroxide concentration. Oper Dent. 2002 Jan-Feb;27(1):12-8. — View Citation
Sulieman MA. An overview of tooth-bleaching techniques: chemistry, safety and efficacy. Periodontol 2000. 2008;48:148-69. doi: 10.1111/j.1600-0757.2008.00258.x. No abstract available. — View Citation
Watt BE, Proudfoot AT, Vale JA. Hydrogen peroxide poisoning. Toxicol Rev. 2004;23(1):51-7. doi: 10.2165/00139709-200423010-00006. — View Citation
Weiner ML, Freeman C, Trochimowicz H, de Gerlache J, Jacobi S, Malinverno G, Mayr W, Regnier JF. 13-week drinking water toxicity study of hydrogen peroxide with 6-week recovery period in catalase-deficient mice. Food Chem Toxicol. 2000 Jul;38(7):607-15. doi: 10.1016/s0278-6915(00)00048-x. — View Citation
* Note: There are 26 references in all — Click here to view all references
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Peroxide level in saliva | Peroxide concentration in saliva (mg/ml) | T0: 1 min after beginning of the bleaching procedure and application of the tray | |
Primary | Peroxide level in saliva | Peroxide concentration in saliva (mg/ml) | T1: 5 min after tray application | |
Primary | Peroxide level in saliva | Peroxide concentration in saliva (mg/ml) | T2: 10 min after tray application | |
Primary | Peroxide level in saliva | Peroxide concentration in saliva (mg/ml) | T3: 30 min after tray application |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02273713 -
The Addition of Nab-paclitaxel (Abraxane) to First Line Treatment of Metastasized Oesophagogastric Carcinoma (ACTION)
|
Phase 1/Phase 2 | |
Terminated |
NCT00531076 -
Safety Study of Bevacizumab (Avastin) With Thoracic Radiation in Non-small Cell Cell Lung Cancer
|
Phase 1 | |
Active, not recruiting |
NCT02397434 -
Adjuvant Radiotherapy After Cystectomy for Muscle Invasive Bladder Cancer
|
N/A | |
Withdrawn |
NCT03342300 -
Pegylated Liposomal Doxorubicin Versus Pirarubicin Plus Ifosfamide, Dacarbazine in Locally Advanced, Unresectable or Metastatic Soft-tissue Sarcoma
|
Phase 2/Phase 3 | |
Active, not recruiting |
NCT02649491 -
Using an Electronic Nose to Predict Gastrointestinal Consequences of Pelvic Radiotherapy
|
N/A | |
Active, not recruiting |
NCT03975452 -
Volume De-escalation in Neoadjuvant Radiochemotherapy of Rectal Cancer
|
N/A | |
Terminated |
NCT00618917 -
MnSOD (Esophageal Protectant) to Prevent Esophagitis During Radiation/Chemotherapy Treatment for Non-Small Cell Lung Cancer (NSCLC)
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT02760823 -
Alpha Lipoic Acid as an Adjuvant Treatment in Acute Phosphide Poisoning
|
Phase 2 | |
Completed |
NCT02864030 -
PAINTER: Polymorphism And INcidence of Toxicity in ERibulin Treatment
|
Phase 4 | |
Completed |
NCT00890448 -
Case Control Study of Pharmacogenomic Factors Associated With Hepatocellular Injury Following Exposure to Lapaquistat Acetate
|
N/A | |
Terminated |
NCT01760356 -
Study of PD/PK/PG Relationships of Tacrolimus and Cyclosporin in Liver Transplant Patients
|
||
Recruiting |
NCT06044623 -
Implementing Geriatric Assessment for Dose Optimization of Cyclin-dependent Kinase (CDK) 4/6-inhibitors in Older Breast Cancer Patients
|
Phase 3 | |
Completed |
NCT01091766 -
Sensitivity of ECG on Detection of Three Different Intravascular Applied Test Doses of Bupivacaine and Epinephrine
|
Phase 4 | |
Completed |
NCT05277480 -
Apatinib With Ifosfamide Plus Etoposide for Relapsed or Refractory Osteosarcoma (OAIE)
|
Phase 2 | |
Recruiting |
NCT03978949 -
Prevention of Radiotherapy Induced Enteropathy by Probiotics (PREP)
|
Phase 3 | |
Completed |
NCT03491371 -
Apatinib for Advanced Sarcoma: Results From Multiple Institutions' Off-label Use
|
N/A | |
Completed |
NCT02143219 -
Efficacy and Tolerance Evaluation in FOLFIRINOX Dose Adjusted in Elderly Patients With a Metastatic Pancreatic Cancer
|
Phase 2 | |
Completed |
NCT02054741 -
Geriatric Assessment Intervention for Reducing Toxicity in Older Patients With Advanced Cancer
|
N/A | |
Not yet recruiting |
NCT06087718 -
Feasibility of the Maastro Applicator in Rectal Cancer
|
N/A | |
Terminated |
NCT02512809 -
Isoflurane-induced Neuroinflammation in Children With Hydrocephalus
|
Phase 3 |